EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access · CC BY 4.0

Neuromodulation as an anticancer strategy

Ashwin Kumaria iD, Keyoumars Ashkan iD

Cancer Medicine · 2023-11 · 12 (21) · 20521-20522

DOI: 10.1002/cam4.6624 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cancer Medicine, online erschienen am 17.10.2023. Verfasst von Ashwin Kumaria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There may be a role for vagus nerve stimulation as an anticancer strategy. This may include the modulation of signalling between nerves and tumour cells and epigenetic influences, in addition to reduction of oxidative stress, anti‐inflammatory and endocrine mechanisms.

Autor:innen und Institutionen

  • Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK.
  • Department of Neurosurgery, King's College Hospital, London, UK.

ORCID-Profile: Ashwin Kumaria, Keyoumars Ashkan

Zitieren

APA

Kumaria, A., & Ashkan, K. (2023). Neuromodulation as an anticancer strategy. Cancer Medicine, 12(21), 20521-20522. https://doi.org/10.1002/cam4.6624

Vancouver

Kumaria A, Ashkan K. Neuromodulation as an anticancer strategy. Cancer Medicine. 2023;12(21):20521-20522. doi:10.1002/cam4.6624

BibTeX
@article{Kumaria2023,
  author = {Kumaria, Ashwin and Ashkan, Keyoumars},
  title = {Neuromodulation as an anticancer strategy},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {21},
  pages = {20521--20522},
  doi = {10.1002/cam4.6624}
}
Kostenlos starten →